Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 23 August 2017 |
| Author/s |
author: Anita Zahlten-Kumeli Athanasios Dimopoulos Hartmut Goldschmidt Philippe Moreau Heinz Ludwig Wee Joo Chng Katja Weisel Roman Hajek Leonard Minuk Thierry Facon Robert Z Orlowski Vania Hungria Ruben Niesvizky Albert Oriol |
| Publication date | August 23, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |